How will the point of care diagnostics market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.
Discover sales for the point of care diagnostics market at segment and national/regional levels. Our report gives you business research, analysis and data.
See sales predictions and discussions for blood glucose testing, coagulation testing, cardiac marker testing and infectious diseases testing segments. Discover opportunities in these markets. Find data you need in our report.
Discover the activities and issue shaping the development of point of care diagnostics market. Through our research and analysis we aim to save you time and help in your decisions.
The market will be driven by the launch of new devices and expansion of test menus. Find R&D trends and commercial opportunities there.
Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations.
Detailed analysis of the global Point of Care Diagnostics Market
Point of Care Diagnostics: World Market Outlook 2012-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies. Discover over 90 tables and charts and a research interview (shown in the accompanying lists).
Why you should buy Point of Care Diagnostics: World Market Outlook 2012-2021
In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for point of care diagnostic devices, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall point of care diagnostic devices market from 2011 to 2021 – seeing where commercial growth will occur
• You will discover sales trends for the main segments – blood glucose testing, coagulation testing, cardiac marker testing and infectious diseases testing – from 2011 to 2021, with detailed discussions of market potential
• You will receive sales forecasts for leading regional/national markets (US, Japan, Europe and Asia), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the point of care diagnostics market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the point of care diagnostics market from 2011 onwards
• You will be able to investigate competition and opportunities influencing the point of care diagnostics market from 2011 onwards
• You will see what will stimulate and restrain the market from 2011
• You will discover the unmet needs in the market, driving the growth from 2011 onwards
• You will view expert opinion from our survey, including full interview transcripts.
You can order this report today
Our report is for everybody needing industry and market analysis for point of care diagnostic devices. Find trends and answers. Avoid missing out – please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Global In Vitro Diagnostic Industry
Table of Contents
1. Executive Summary
1.1 The Point of Care (POC) Diagnostics Market Review
1.2 Aims, Scope and Format of the Report
1.2.1 Chapter Outlines
1.3 Research and Analysis Methods
2. Introduction to In-Vitro Diagnostics and POC Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying IVD: EDMA Classification
2.2.1 Clinical Chemistry
2.2.2 Immunochemistry
2.2.3 Haematology
2.2.4 Microbiology
2.2.5 Genetic Testing
2.3 Point of Care (POC) Diagnostics
2.3.1 Advantages and Disadvantages of POC Diagnostics
2.4 Regulation of the IVD and POC Market
2.4.1 FDA Classifications
2.4.2 FDA and CLIA Regulation of IVD and POC Tests
2.4.3 Regulation of IVD/POC Diagnostics in the EU
3. The Point of Care Diagnostics Market, 2010-2021
3.1 Point of Care Diagnostics in the IVD Market, 2010
3.2 Blood Glucose Testing is the Largest Contributor to the POC Market Sales
3.3 Self Testing Constituted the largest segment in the POC Market by the Point of Delivery, 2010
3.4 Global IVD Market Forecast, 2011-2021
3.5 Point of Care Diagnostics Market Forecast, 2011-2015
3.6 Point of Care Diagnostics Market Forecast, 2015-2021
3.7 POC Diagnostics Gaining Greater Share of the IVD Market
3.8 Clinical Diagnostics Market Forecast, 2011-2015
3.9 Clinical Diagnostics Market Forecast, 2015-2021
3.10 Sales Forecast for POC Diagnostics Market Segments, 2011-2021
3.10.1 Changing Market Shares of the Leading Segments
4. Leading National Markets for POC Diagnostics, 2010-2021
4.1 Global POC Diagnostics Market by Regions, 2010
4.1.1 Breakdown of the European Market, 2010
4.2 The US POC Diagnostics Market: Forecast and Outlook, 2011-2021
4.3 The Japanese POC Diagnostics Market: Forecast and Outlook, 2011-2021
4.4 The European POC Diagnostics Markets: Forecasts and Outlook, 2011-2021
4.4.1 Variation In the European Markets
4.5 The Asian POC Diagnostics Market: Forecast and Outlook, 2011-2021
5. Blood Glucose Testing Market, 2010-2021
5.1 Market Overview
5.2 POC Blood Glucose Testing Market in 2010
5.2.1 POC Blood Glucose Testing Market by Type of Meter
5.2.2 POC Blood Glucose Testing Market Segment by Components
5.2.3 Roche is the Market Leader in the Blood Glucose Testing Market, 2010
5.2.4 The US is the Largest Market for POC Blood Glucose Testing
5.3 Continuous Glucose Monitoring (CGM) Systems vs. Fingertip Testing
5.3.1 The CGM Pipeline
5.4 POC Blood Glucose Testing Market, 2011-2015
5.5 POC Blood Glucose Testing Market, 2015-2021
6. POC Coagulation Testing Market, 2010-2021
6.1 The POC Coagulation Testing Market in 2010
6.1.1 PT/INR Monitoring is the Largest Segment in the POC Coagulation Testing Market
6.1.2 Products Available in the POC Coagulation Testing Market, 2010
6.1.3 Roche Dominates the POC Coagulation Testing Market with CoaguChek XS System
6.2 The PT/INR POC Testing Market, 2010
6.2.1 Patient Self Testing is the Smallest, But Fastest Growing Segment
6.2.1.1 Coagulation Self-Monitoring: Reimbursement Status
6.2.2 Test Strips Generate 80% of the Sales in the PT/INR POC Testing Market
6.2.3 The US is the Largest Market for POC PT/INR Testing
6.3 POC Coagulation Testing Will Witness Strong Growth to 2015
6.4 POC Coagulation Testing Market Forecast, 2015-2021
6.5 POC Coagulation Test Systems in Development
6.5.1 Portable Coagulation Monitor, Entegrion
6.5.2 Blood Coagulation Monitor, Bio-AMD
6.5.3 Siemens-Universal Biosensors Collaboration
6.6 Drivers for Growth
7. POC Cardiac Marker Testing Market, 2010-2021
7.1 POC Testing for Cardiac Markers is Less Common than Laboratory Testing, 2010
7.2 Majority of Cardiac Marker Testing is Conducted in Critical Care Settings
7.3 Most Commonly Used Markers for POC Testing
7.4 Domination by a Few Large Diagnostic Companies
7.5 Leading Products in the POC Cardiac Marker Testing Market in 2010
7.5.1 i-STAT is the Leading Product in the Market
7.6 Cardiac Marker Testing: Huge Opportunities for Growth
7.7 POC Cardiac Marker Tests Under Development, 2011
7.7.1 Handheld Device (bioMerieux/Royal Philips Electronics)
7.7.2 QL Care Analyzer (CardioGenics)
7.8 High Entry Barriers: Challenges for the New Entrants
7.9 POC Cardiac Marker Testing Market, 2011-2015
7.10 POC Cardiac Marker Testing Market, 2015-2021
8. POC Infectious Diseases Testing Market, 2010-2021
8.1 Infectious Diseases Testing
8.2 HIV/AIDS
8.2.1 HIV POC Testing
8.2.2 The US HIV Rapid Testing Market, 2010
8.2.3 Some Other Rapid HIV Testing Kits Marketed Outside the US
8.2.4 HIV POC Tests Pipeline, 2011
8.2.5 Driving Factors for Growth of HIV Rapid Testing: Past and Future
8.3 Influenza
8.3.1 Current State of Influenza POC Testing Market
8.4 Hepatitis B & C
8.4.1 Hepatitis POC Testing Market in 2010
8.4.2 First Rapid HCV Test Approved in the US
8.4.3 Driving Factors for Growth of Hepatitis Rapid Testing
8.5 POC Infectious Disease Testing Market, 2011-2021
9. SWOT Analysis of the POC Diagnostics Market, 2011-2021
9.1 Strengths and Weaknesses of the Sector
9.1.1 Better Patient and Disease Management
9.1.2 Improved Access to Diagnostics
9.1.3 IVDs Are Vital to Clinical Decision Making
9.1.4 The Cost of POC Tests
9.1.5 Educating the End-Users
9.2 Opportunities and Threats
9.2.1 Growth of Microfluidics Use for POC Diagnostics
9.2.1.1 mChip, University of Columbia
9.2.2 Opportunities in New Areas
9.2.2.1 Diagnostics for Woundcare
9.2.2.2 Diagnostics for Syphilis
9.2.3 Expansion into Developing National Markets and Lifestyle Diseases Will Drive the Market
9.2.4 High-Entry Barriers in the POC Blood Glucose Testing Market
9.2.5 Medical Device Excise Tax: A Threat to the OEMs
10. Expert Opinion
10.1 Interview with Dr. Michael J. Lochhead, MBio Diagnostics, USA
10.1.1 On the POC Diagnostics Market
10.1.2 Opportunity for MBio Diagnostics in the POC Market
10.1.3 Opportunities and Threats in the POC Diagnostics Market
10.1.4 Growth in the POC Diagnostics Market
11. Conclusions
11.1 Overview
11.2 Commercial Drivers for the Adoption of POC Tests
11.3 Commercial Restraints in the POC Diagnostics Market
11.4 Significant Growth of POC Diagnostics Market from 2010 to 2021
11.5 Future Outlook and Concluding Remarks
Appendix A
Appendix B
Visiongain report evaluation form
List of Tables
Table 2.1 Advantages and Disadvantages of POC Diagnostics
Table 3.1 Laboratory & POC Diagnostics Market ($bn), 2010
Table 3.2 POC Market by Leading Segments, Sales ($bn) and Market Share (%), 2010
Table 3.3 Self Testing & Professional Testing in the POC Market ($bn), 2010
Table 3.4 IVD Market and Submarkets Sales ($bn) Forecasts, 2010-2021
Table 3.5 World POC Diagnostics Market Forecast ($bn), 2010-2015
Table 3.6 World POC Diagnostics Market Forecast ($bn), 2015-2021
Table 3.7 Market Shares (%) of POC Diagnostics and Clinical Diagnostics in the IVD Market, 2010, 2015 & 2021
Table 3.8 World Clinical Diagnostics Market Forecast ($bn), 2010-2015
Table 3.9 World Clinical Diagnostics Market Forecast ($bn), 2015-2021
Table 3.10 Sales Forecasts ($bn) for Leading Segments of the POC Diagnostics Market, 2010-2021
Table 3.11 Market Shares (%) of Leading Segments in the POC Diagnostics Market, 2010, 2015 & 2021
Table 4.1 World POC Diagnostics Market: Regional Sales ($bn), 2010
Table 4.2 European POC Diagnostics Market ($bn) by Leading Countries, 2010
Table 4.3 The US POC Diagnostics Market Forecast ($bn), 2010-2021
Table 4.4 The Japanese POC Diagnostics Market Forecast ($bn), 2010-2021
Table 4.5 The European POC Diagnostics Market Forecast ($bn), 2010-2021
Table 4.6 The Asian POC Diagnostics Market Forecast ($bn), 2010-2021
Table 5.1 Global POC Blood Glucose Testing Devices Market ($bn) by Type of Meter, 2010
Table 5.2 Global POC Blood Glucose Testing Devices Market ($bn) by Component, 2010
Table 5.3 Global POC Blood Glucose Testing Devices Market ($bn) by Leading Companies, 2010
Table 5.4 List of Some Other Companies in the POC Blood Glucose Testing Market, 2011
Table 5.5 Leading National Markets for POC Blood Glucose Testing Market ($bn), 2010
Table 5.6 Advantages of CGMs over Fingerstick Testing Systems, 2011
Table 5.7 Marketed CGMs, 2011
Table 5.8 CGM Pipeline, 2011
Table 5.9 The POC Blood Glucose Testing Market Forecast ($bn), 2010-2015
Table 5.10 The POC Blood Glucose Testing Market Forecast ($bn), 2015-2021
Table 6.1 Global POC Coagulation Testing Market ($m) by Marker, 2010
Table 6.2 List of Some Products in the POC Coagulation Testing Market, 2011
Table 6.3 Global POC Coagulation Testing Market ($m) by Leading Companies, 2010
Table 6.4 PT/INR POC Testing Market ($m) by Point of Use, 2010
Table 6.5 Reimbursement for Coagulation Self-Monitoring In the US and Some European Countries, 2011
Table 6.6 The Price of Some POC PT/INR Testing Systems, 2010
Table 6.7 PT/INR POC Testing Market ($m) by Components, 2010
Table 6.8 PT/INR POC Testing Market ($m) by Region, 2010
Table 6.9 The POC Coagulation Testing Market Forecast ($bn), 2010-2015
Table 6.10 The POC Coagulation Testing Market Forecast ($bn), 2015-2021
Table 6.11 List of Some POC Coagulation Tests Under Development, 2011
Table 7.1 Cardiac Markers, 2011
Table 7.2 Time to Elevation for Some Cardiac Markers
Table 7.3 Leading Companies in the POC Cardiac Marker Testing Market, 2010
Table 7.4 Leading Products in the POC Cardiac Marker Testing Market, 2011
Table 7.5 Some More Products in the POC Cardiac Marker Testing Market, 2011
Table 7.6 Sales ($m) of i-STAT and RAMP System, 2010
Table 7.7 The POC Cardiac Marker Testing Market Forecast ($bn), 2010-2015
Table 7.8 The POC Cardiac Marker Testing Market Forecast ($bn), 2015-2021
Table 8.1 The US HIV Rapid Testing Market ($m) by Leading Products, 2010
Table 8.2 Some More Products in the Rapid HIV Testing Market, 2011
Table 8.3 List of Some HIV POC Tests Under Development, 2011
Table 8.4 List of Some Products in the Rapid Influenza Testing Market, 2011
Table 8.5 List of Some Products in the POC Hepatitis Testing Market, 2011
Table 8.6 The POC Infectious Diseases Testing Market Forecast ($bn), 2010-2015
Table 8.7 The POC Infectious Diseases Testing Market Forecast ($bn), 2015-2021
Table 9.1 SWOT Analysis of the POC Diagnostics Market
Table 9.2 Cost Comparison of Some POC and Clinical Diagnostic Tests
Table 11.1 Sales ($bn) of Leading Segments in the POC Diagnostics Market, 2010, 2015 & 2021
List of Figures
Figure 3.1 Market Share (%): Laboratory Testing & POC Testing, 2010
Figure 3.2 Market Shares (%) of Leading Segments in the POC Diagnostics Market, 2010
Figure 3.3 Market Share (%) of Self Testing & Professional Testing in the POC Market, 2010
Figure 3.4 World IVD Market Forecast ($bn), 2010-2021
Figure 3.5 World POC Diagnostics Market Forecast ($bn), 2010-2015
Figure 3.6 World POC Diagnostics Market Forecast ($bn), 2015-2021
Figure 3.7 World POC Diagnostics Market Share (%) in the IVD Market, 2015
Figure 3.8 World POC Diagnostics Market Share (%) in the IVD Market, 2021
Figure 3.9 World Clinical Diagnostics Market Forecast ($bn), 2010-2015
Figure 3.10 World Clinical Diagnostics Market Forecast ($bn), 2015-2021
Figure 3.11 Sales Forecasts ($bn) for Leading Segments of the POC Diagnostics Market, 2010-2015
Figure 3.12 Sales Forecasts ($bn) for Leading Segments of the POC Diagnostics Market, 2015-2021
Figure 3.13 Market Shares (%) of Leading Segments in the POC Diagnostics Market, 2015
Figure 3.14 Market Shares (%) of Leading Segments in the POC Diagnostics Market, 2021
Figure 4.1 POC Diagnostics Market: Regional Market Shares (%), 2010
Figure 4.2 Leading European POC Diagnostics Market Shares (%), 2010
Figure 4.3 The US POC Diagnostics Market Forecast ($bn), 2010-2021
Figure 4.4 The Japanese POC Diagnostics Market Forecast ($bn), 2010-2021
Figure 4.5 The European POC Diagnostics Market Forecast ($bn), 2010-2021
Figure 4.6 The Asian POC Diagnostics Market Forecast ($bn), 2010-2021
Figure 5.1 Market Shares (%) of Fingerstick Testing and CGM Devices in the POC Blood Glucose Monitoring Market, 2010
Figure 5.2 Market Shares (%) of Meters, Test Strips and Other Devices in the POC Blood Glucose Testing Market, 2010
Figure 5.3 Market Shares (%) of Leading Companies in the POC Blood Glucose Testing Market, 2010
Figure 5.4 Market Shares (%) of Leading National Markets in the POC Blood Glucose Testing Market, 2010
Figure 5.5 The POC Blood Glucose Testing Market Forecast ($bn), 2010-2015
Figure 5.6 The POC Blood Glucose Testing Market Forecast ($bn), 2015-2021
Figure 6.1 Market Share (%) of POC Coagulation Testing Market by Type of Marker, 2010
Figure 6.2 Market Share (%) of Roche in the POC Coagulation Testing Market, 2010
Figure 6.3 Market Share (%) of the PT/INR POC Testing Market by Point of Use, 2010
Figure 6.4 Market Share (%) of Meters and Strips in the PT/INR POC Testing Market, 2010
Figure 6.5 Regional Market Share (%) of the PT/INR POC Testing Market, 2010
Figure 6.6 The POC Coagulation Testing Market Forecast ($bn), 2010-2015
Figure 6.7 The POC Coagulation Testing Market Forecast ($bn), 2015-2021
Figure 7.1 Market Share (%) of Four Leading Companies in the POC Cardiac Testing Market, 2010
Figure 7.2 Market Share (%) of i-STAT and RAMP in the Global POC Cardiac Marker Testing Market, 2010
Figure 7.3 The POC Cardiac Marker Testing Market Forecast ($bn), 2010-2015
Figure 7.4 The POC Cardiac Marker Testing Market Forecast ($bn), 2015-2021
Figure 8.1 Market Share (%) of Leading Products in the US HIV Rapid Testing Market, 2010
Figure 8.2 The POC Infectious Diseases Testing Market Forecast ($bn), 2010-2015
Figure 8.3 The POC Infectious Diseases Testing Market Forecast ($bn), 2015-2021
Figure 11.1 The Classification of POC Diagnostics
Figure 11.2 POC Diagnostics Market: World Sales Forecast ($bn), 2010, 2015 and 2021
Companies Listed
3M
A. Menarini
Abbott
Advanced Liquid Logic
AgaMatrix
AIMEDICS
Alere
Alfa Scientific Designs
American College of Cardiology (ACC)
American Heart Association (AHA)
ArKal Medical
Arkray
Bayer
BBI Healthcare
Bbraun
BD Biosciences
Becton Dickinson
Bio-AMD
BioHelix Corporation
bioLytical Laboratories
bioMerieux
Bionime
Bio-Rad Laboratories
Biorasis
Burnet Institute
Calypte Biomedical
CardioGenics
Center for Diseases Control and Prevention
Centers for Device and Radiological Health (CDRH)
Centers for Medicare & Medicaid Services (CMS)
Cepheid
Chembio Diagnostic Systems
CoaguSense
Daktari Diagnostics
DexCom
Diabetic Supply of Suncoast
Diagnostic Devices
Diagnostics for the Real World
DiME
Echo Therapeutics
Entegrion
Entra Health Systems
European Commission (EC)
European Diagnostics Manufacturers Association (EDMA)
EY Laboratories
Fifty50 Medical
Food and Drug Administration (FDA)
Fora Care
Gemeinsamer Bundesausschuss
Genesis Health Technology
Genzyme
German Federal Ministry of Health
Gluco Com
GluMetrics
GluSense
Health Protection Agency (HPA)
Helena Laboratories
Hemocellular Therapeutics
IME-DC
IND Diagnostics
Infopia
Instrumentation Laboratory
International Diabetes Federation
International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP)
International Technidyne Corporation
IQuum
JANT Pharmacal Corporation
Johnson & Johnson
Joint United Nations Programme on HIV/AIDS (UNAIDS)
LifeScan
LifeSign
MBio Diagnostics
Medix Biochemica
MedMira
Medtronic
Meikang Biotech
Menarini
Mendor
Meridian Bioscience
Micronics
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Human Resource and Social Security (MOHRSS)
MIZUHO MEDY Company
National Health Service (NHS)
NexusDx
Nipro Diagnostics
Northwestern Global Health Foundation
Nova Biomedical
Oak Tree International Holdings
Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
OraSure Technologies
Partec
PointCare Technologies
Princeton BioMeditech Corporation
Quidel Corporation
Randox Laboratories
Remel
Roche Diagnostics
Royal Philips Electronics
Runbio Biotech Company
SA Scientific
Savyon Diagnostics
Sekisui Medical Company
Siemens Healthcare Diagnostics
Sony Corporation
Spirit Healthcare
Systagenix Wound Management
Thermofisher
Trinity Biotech
U.S. Diagnostics
Ultradian Diagnostics
Unimed International
Universal Biosensor
University of Calgary
University of Columbia
US Department of Defense (DoD)
Walmart
Wave 80 Biosciences
Werfen Group
World Health Organization (WHO)
YD Diagnostics
Ypsomed
Zyomyx
